sulpiride has been researched along with Dyskinesia, Drug-Induced in 81 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties." | 5.28 | Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990) |
| " In this long-term, open, randomised, multicentre trial, patients with chronic or subchronic schizophrenia received amisulpride (n =370) or haloperidol (n = 118) for 12 months." | 5.09 | Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group. ( Colonna, L; Dondey-Nouvel, L; Rein, W; Saleem, P, 2000) |
| "To review the pharmacology, pharmacokinetics, clinical investigations, and adverse effects of sulpiride as a treatment for schizophrenia." | 4.79 | Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. ( Caley, CF; Weber, SS, 1995) |
| "Following ten years of continuous olanzapine therapy a 51 years old man developed a Gilles de la Tourette syndrome which disappeared after changing to amisulprid." | 3.74 | [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia]. ( Friederich, M; Kozian, R, 2007) |
| " Extrapyramidal tolerability was better in the ASP group, as demonstrated by smaller increases in the Simpson-Angus Scale, the AIMS, and the Barnes Akathisia Scale in ANCOVA analyses with dosage as covariate." | 2.69 | Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group. ( Adler, G; Benkert, O; Gattaz, WF; Gründer, G; Hillert, A; Philipp, M; Rein, W; Sauer, H; Schröder, J; Wetzel, H, 1998) |
| "Eleven patients with Huntington's disease and nine patients with tardive dyskinesia participated in a randomised double-blind crossover trial of sulpiride (as sole antidopaminergic therapy) versus placebo." | 2.65 | A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. ( Marsden, CD; Quinn, N, 1984) |
| "Sulpiride is an important tool for elucidating both the practical and heuristic aspects of subtypes of dopamine receptors and is a lead in the search for compounds that selectively affect dopaminergic mechanisms." | 2.65 | Sulpiride in tardive dyskinesia. ( Casey, DE; Gerlach, J; Simmelsgaard, H, 1979) |
| "Sulpiride is a new and chemically different neuroleptic." | 2.64 | An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels. ( Gallant, DM; Kessler, C; Mielke, DH, 1977) |
| "Risperidone appears to be an effective therapy, but several authors report cases of TD during treatment." | 2.41 | Tardive dyskinesias and antipsychotics: a review. ( Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM, 2002) |
| "Aripiprazole treatment at 3 mg/day improved tardive oromandibular dystonia without worsening Parkinsonism." | 1.37 | Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia. ( Ikawa, M; Imai, N, 2011) |
| "Although schizophrenia affects all age groups, late or very-late-onset schizophrenia-like psychosis has not been well studied and various treatment issues remain unresolved." | 1.35 | Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis. ( Papadimitriou, GN; Paparrigopoulos, TJ; Politis, AM; Psarros, C; Theleritis, CG, 2009) |
| "Aripiprazole is a new generation antipsychotic drug with a partial agonist effect on dopamine D2 and D3 receptors." | 1.35 | Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. ( Adan-Manes, J; Garcia-Parajua, P, 2009) |
| "Acute and chronic administration of vigabatrin, a selective inactivator of GABA-T, suppresses haloperidol-induced dyskinesias at low doses without preventing the enhancement of striatal dopamine D2 receptor density or the development of vacuous chewing movements." | 1.29 | Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin. ( Elands, J; Gobaille, S; Grauffel, C; Knödgen, B; Moran, P; Sarhan, S; Seiler, N; van den Buuse, M, 1995) |
| "Sulpiride has the same possible side effects than classic neuroleptics." | 1.29 | Tardive akathisia due to sulpiride. ( Arce, A; Gorospe, A; López de Munain, A; Martí Massó, JF; Poza, JJ, 1994) |
| "Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods." | 1.28 | Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992) |
| "Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties." | 1.28 | Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (32.10) | 18.7374 |
| 1990's | 22 (27.16) | 18.2507 |
| 2000's | 24 (29.63) | 29.6817 |
| 2010's | 9 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sevincok, L | 1 |
| Balci, V | 1 |
| Akyildiz, U | 1 |
| Psarros, C | 1 |
| Theleritis, CG | 1 |
| Paparrigopoulos, TJ | 1 |
| Politis, AM | 1 |
| Papadimitriou, GN | 1 |
| Adan-Manes, J | 1 |
| Garcia-Parajua, P | 1 |
| Mendhekar, DN | 3 |
| Andrade, C | 2 |
| Kim, HJ | 1 |
| Cho, JY | 1 |
| Cho, YJ | 1 |
| Hong, KS | 1 |
| Kumar, A | 1 |
| Strech, D | 1 |
| Rizos, E | 1 |
| Douzenis, A | 1 |
| Gournellis, R | 1 |
| Christodoulou, C | 1 |
| Lykouras, LP | 1 |
| Guriz, O | 1 |
| Ekinci, AE | 1 |
| Orsel, S | 1 |
| Ekinci, O | 1 |
| Goyal, N | 2 |
| Sinha, VK | 2 |
| Chen, CC | 1 |
| Chen, YY | 1 |
| Hung, GC | 1 |
| Martí Massó, JF | 2 |
| Ruiz-Martínez, J | 1 |
| Bergareche, A | 1 |
| López de Munain, A | 2 |
| Imai, N | 1 |
| Ikawa, M | 1 |
| Garg, S | 1 |
| Lee, SJ | 1 |
| Lee, JH | 1 |
| Jung, SW | 1 |
| Koo, BH | 1 |
| Choi, TY | 1 |
| Lee, KH | 1 |
| Ohye, C | 1 |
| Shibazaki, T | 1 |
| Correll, CU | 1 |
| Leucht, S | 1 |
| Kane, JM | 1 |
| Kovoor, A | 1 |
| Seyffarth, P | 1 |
| Ebert, J | 1 |
| Barghshoon, S | 1 |
| Chen, CK | 1 |
| Schwarz, S | 1 |
| Axelrod, JD | 1 |
| Cheyette, BN | 1 |
| Simon, MI | 1 |
| Lester, HA | 1 |
| Schwarz, J | 1 |
| Müller, JL | 1 |
| Putzhammer, A | 1 |
| Hajak, G | 1 |
| Raja, M | 1 |
| Azzoni, A | 1 |
| Müller, MJ | 1 |
| Regenbogen, B | 1 |
| Härtter, S | 1 |
| Eich, FX | 2 |
| Hiemke, C | 1 |
| Alonso-Navarro, H | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Fountoulakis, KN | 1 |
| Panagiotidis, P | 1 |
| Siamouli, M | 1 |
| Kantartzis, S | 1 |
| Mavridis, T | 1 |
| Iacovides, A | 1 |
| Kaprinis, G | 1 |
| Limosin, F | 1 |
| Linden, M | 1 |
| Pyrkosch, L | 1 |
| Kozian, R | 1 |
| Friederich, M | 1 |
| Bjørndal, N | 1 |
| Casey, D | 1 |
| Gerlach, J | 5 |
| Leclere, A | 1 |
| Plichart, P | 1 |
| Destee, A | 2 |
| Warot, P | 1 |
| Pi, EH | 1 |
| Simpson, GM | 1 |
| Häggström, JE | 2 |
| Casey, DE | 4 |
| Rosengarten, H | 1 |
| Schweitzer, JW | 1 |
| Friedhoff, AJ | 1 |
| Quinn, N | 1 |
| Marsden, CD | 2 |
| Offermeier, J | 1 |
| van Rooyen, JM | 1 |
| Bárány, S | 1 |
| Gunne, LM | 1 |
| Laplane, D | 1 |
| Dougados, M | 1 |
| Macron, JM | 1 |
| Magelund, G | 1 |
| Christensen, TR | 1 |
| Parsons, B | 1 |
| Togasaki, DM | 1 |
| Kassir, S | 1 |
| Przedborski, S | 1 |
| Schwartz, M | 2 |
| Weller, B | 1 |
| Erdreich, M | 1 |
| Sharf, B | 2 |
| Seiler, N | 1 |
| Grauffel, C | 1 |
| Elands, J | 1 |
| van den Buuse, M | 1 |
| Knödgen, B | 1 |
| Sarhan, S | 1 |
| Moran, P | 1 |
| Gobaille, S | 1 |
| Caley, CF | 1 |
| Weber, SS | 1 |
| Kai, S | 1 |
| Kai, H | 1 |
| Tashiro, H | 1 |
| Parry, TJ | 1 |
| Eberle-Wang, K | 1 |
| Lucki, I | 1 |
| Chesselet, MF | 1 |
| Nakamura, S | 1 |
| Akiguchi, I | 1 |
| Maj, J | 1 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Kołodziejczyk, K | 1 |
| Marta-Moreno, E | 1 |
| Gracia-Naya, M | 1 |
| Marzo-Sola, ME | 1 |
| Freeman, HL | 1 |
| Poza, JJ | 1 |
| Gorospe, A | 1 |
| Arce, A | 1 |
| Wetzel, H | 1 |
| Gründer, G | 1 |
| Hillert, A | 1 |
| Philipp, M | 1 |
| Gattaz, WF | 1 |
| Sauer, H | 1 |
| Adler, G | 1 |
| Schröder, J | 1 |
| Rein, W | 2 |
| Benkert, O | 1 |
| Giladi, N | 1 |
| Melamed, E | 2 |
| Hauber, W | 1 |
| Lutz, S | 1 |
| Colonna, L | 1 |
| Saleem, P | 1 |
| Dondey-Nouvel, L | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| Devos, D | 1 |
| Defebvre, L | 1 |
| Caron, J | 1 |
| Marchese, G | 1 |
| Casu, MA | 1 |
| Bartholini, F | 1 |
| Ruiu, S | 1 |
| Saba, P | 1 |
| Gessa, GL | 1 |
| Pani, L | 1 |
| Llorca, PM | 1 |
| Chereau, I | 1 |
| Bayle, FJ | 1 |
| Lancon, C | 1 |
| Mielke, DH | 1 |
| Gallant, DM | 1 |
| Kessler, C | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Nohria, V | 1 |
| Owen, RT | 1 |
| Simmelsgaard, H | 1 |
| Lees, AJ | 1 |
| Lander, CM | 1 |
| Stern, GM | 1 |
| Petit, H | 1 |
| Graux, P | 1 |
| Durocher, AM | 1 |
| Luquin, MR | 1 |
| Scipioni, O | 1 |
| Vaamonde, J | 1 |
| Gershanik, O | 1 |
| Obeso, JA | 1 |
| Caporali, MG | 1 |
| Scotti de Carolis, A | 1 |
| Popoli, P | 1 |
| Herraiz, J | 1 |
| Cano, A | 1 |
| Roquer, J | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| Boyer, P | 1 |
| Lecrubier, Y | 1 |
| Puech, AJ | 1 |
| Moguillansky, L | 1 |
| Lanyi, G | 1 |
| Achiron, A | 1 |
| Zoldan, Y | 1 |
| Zarebinski, JM | 1 |
| Royds, JN | 1 |
| Bédard, PJ | 1 |
| Boucher, R | 1 |
| Amore, M | 1 |
| Cerisoli, M | 1 |
| Campanile, S | 1 |
| Campanile, A | 1 |
| Rupniak, NM | 1 |
| Briggs, RS | 1 |
| Petersen, MM | 1 |
| Mann, S | 1 |
| Reavill, C | 1 |
| Jenner, P | 1 |
| Sandyk, R | 1 |
| Schiff, AA | 1 |
| Chouza, C | 1 |
| Caamano, JL | 1 |
| Romero, S | 1 |
| Lorenzo, J | 1 |
| Feres, S | 1 |
| Horikawa, H | 1 |
| Konagaya, M | 1 |
| Mano, Y | 1 |
| Takayanagi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
9 reviews available for sulpiride and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials a | 2009 |
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepin | 2004 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; | 2006 |
Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Clozapine; Dibenzazepines; Dose-Response | 1983 |
Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.
Topics: Animals; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Clinical Trials as Topic; Double | 1995 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Mov | 1993 |
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double- | 1997 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; | 2000 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Ola | 2002 |
9 trials available for sulpiride and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
Topics: Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Disea | 2012 |
Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Clozapine; Dibenzazepines; Dose-Response | 1983 |
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskin | 1984 |
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Dru | 1998 |
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induce | 2000 |
An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evalua | 1977 |
Sulpiride in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male | 1979 |
Treatment of positive and negative symptoms: pharmacologic approaches.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug | 1990 |
Sulpiride in tardive dyskinesia.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Long | 1990 |
64 other studies available for sulpiride and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Tardive dystonia associated with low-dose of amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Humans; Mal | 2008 |
Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
Topics: Age of Onset; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; | 2009 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug T | 2009 |
Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism.
Topics: Amisulpride; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Hypothyroidism; Male; Sulpiride | 2009 |
Levosulpiride-induced resting orolingual tremor.
Topics: Dopamine Antagonists; Dyskinesia, Drug-Induced; Dyspepsia; Facial Muscles; Female; Humans; Middle Ag | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskine | 2009 |
Amisulpride-induced tardive dystonia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography | 2010 |
Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia | 2010 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Hum | 2010 |
Possible rabbit syndrome with amisulpride.
Topics: Aged; Amisulpride; Dyskinesia, Drug-Induced; Humans; Male; Sulpiride | 2010 |
Amisulpride may worsen dyskinesia and trigger new-onset dyskinetic movements.
Topics: Aged; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Schizophrenia; Su | 2010 |
[Parkinsonism induced by sulpiride and veralipride: two different stories].
Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Hum | 2011 |
Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
Topics: Aged, 80 and over; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Jaw; Movement Disorders; | 2011 |
Levosulpiride-induced rabbit syndrome.
Topics: Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride; Young A | 2013 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio | 2001 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych | 2005 |
[Functional magnetic resonance tomography of central motor areas in schizophrenic patients].
Topics: Amisulpride; Antipsychotic Agents; Biomechanical Phenomena; Dyskinesia, Drug-Induced; Gait Apraxia; | 2005 |
Tardive dyskinesia after long-term veralipride treatment.
Topics: Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Psychotic Disorders; Sulpiride | 2005 |
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dose-Response Relatio | 2007 |
Tardive blepharospasm beginning after withdrawal of veralipride.
Topics: Antipsychotic Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Substanc | 2006 |
Amisulpride-induced tardive dyskinesia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Dru | 2006 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, | 2007 |
[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Indu | 2007 |
Dopamine antagonist and agonist treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benserazide; Benzimidazoles; Dopamine; Dopamine Antagonists; Dyskinesia, Drug- | 1980 |
[Use of sultopride in a case of neuroleptic-induced late dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
[Dyskinesia induced by veralipride].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Sulpiride | 1983 |
Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
Topics: Animals; Antipsychotic Agents; Cebus; Dyskinesia, Drug-Induced; Dystonia; Metoclopramide; Sulpiride | 1984 |
Sulpiride in tardive dyskinesia.
Topics: Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Parkinson Disease, Sec | 1984 |
Induction of oral dyskinesias in naive rats by D1 stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dysk | 1983 |
Dopamine inhibitory and excitatory systems in tardive dyskinesias.
Topics: Animals; Apomorphine; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced | 1983 |
Application of a primate model for tardive dyskinesia.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Histamine An | 1983 |
[Dyskinesias due to veralipride].
Topics: Climacteric; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
Topics: Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Receptors, Dopamine; Sulpiride | 1981 |
Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Binding Sites; Binding, Competitive; Corpus Striatum; Dyskinesia, Dru | 1995 |
Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fem | 1995 |
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Body Weight; Brain; Dyskinesia, Drug-Induced | 1995 |
Tardive dyskinesia affected by occlusal treatment--a case report.
Topics: Aged; Denture, Complete; Dyskinesia, Drug-Induced; Female; Humans; Mandibular Diseases; Occlusal Spl | 1994 |
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dyskinesia, Drug-Induced; Haloperidol; Kainic A | 1994 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; | 1997 |
[Respiratory dyskinesia induced by veralipride].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Menopause; Middle Aged; Respiration | 1997 |
Tardive akathisia due to sulpiride.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dopamine An | 1994 |
Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.
Topics: Aged; Antiparkinson Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middl | 1999 |
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat.
Topics: Animals; Autoradiography; Benzazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dysk | 1999 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; | 2000 |
Choreic movements induced by cibenzoline: an Ic class antiarrhythmic effect?
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chorea; Dopamine Antagonists; Dyskinesia, Drug-I | 2000 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; D | 2002 |
Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.
Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Mice; Motor Acti | 1978 |
Tiapride and sulpiride in Parkinson's disease.
Topics: Benzamides; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Sulpiride | 1978 |
[Sulpiride and tiapride in neurology. Introductory report].
Topics: Basal Ganglia Diseases; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Sulpiride; Tiapamil Hy | 1979 |
[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].
Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride; | 1979 |
Sulpiride and oxiperomide in tardive dyskinesia.
Topics: Aged; Benzimidazoles; Dyskinesia, Drug-Induced; Female; Humans; Male; Sulpiride | 1979 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1992 |
N-ethyl-carboxamide adenosine inhibits perioral dyskinesias induced by sulpiride + SKF 38393 in rabbits.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine-5'-(N-ethylcarboxam | 1992 |
[Tardive dyskinesia due to sulpiride].
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride | 1991 |
Sulpiride-induced tardive dystonia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; | 1990 |
Tardive dyskinesia induced by sulpiride.
Topics: Aged; Depression; Dyskinesia, Drug-Induced; Female; Gastrointestinal Diseases; Humans; Male; Middle | 1990 |
Sulpiride in tardive dyskinesia.
Topics: Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Sulpiride | 1990 |
Effect of D1 receptor stimulation in normal and MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 1989 |
Pisa syndrome. Report of a case.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Schiz | 1988 |
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Choline O-Acetyltransferase; Clozapine; Corpus Striatu | 1986 |
Tardive dyskinesia induced by sulpiride in a patient with hypothyroidism.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Hypothyroidism; Sulpiride | 1986 |
Sulpiride and the potentiation of progestogen only contraception.
Topics: Animals; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride | 1985 |
Extrapyramidal effects of benzamides.
Topics: Basal Ganglia Diseases; Benzamides; Dyskinesia, Drug-Induced; Humans; Metoclopramide; Movement Disor | 1985 |
[Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
Topics: Aged; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Movement | 1985 |